Intellectual Property partner Lisa Ferri (New York) is quoted on the Federal Circuit decision that ruled GlaxoSmithKline LLC's leukemia drug Arzerra® does not infringe a Biogen Idec Inc. and Genentech Inc. patent covering an antibody therapy.

Downloads –

Related Capabilities